Sekino, Y.; Han, X.; Kawaguchi, T.; Babasaki, T.; Goto, K.; Inoue, S.; Hayashi, T.; Teishima, J.; Shiota, M.; Yasui, W.;
et al. TUBB3 Reverses Resistance to Docetaxel and Cabazitaxel in Prostate Cancer. Int. J. Mol. Sci. 2019, 20, 3936.
https://doi.org/10.3390/ijms20163936
AMA Style
Sekino Y, Han X, Kawaguchi T, Babasaki T, Goto K, Inoue S, Hayashi T, Teishima J, Shiota M, Yasui W,
et al. TUBB3 Reverses Resistance to Docetaxel and Cabazitaxel in Prostate Cancer. International Journal of Molecular Sciences. 2019; 20(16):3936.
https://doi.org/10.3390/ijms20163936
Chicago/Turabian Style
Sekino, Yohei, Xiangrui Han, Takafumi Kawaguchi, Takashi Babasaki, Keisuke Goto, Shogo Inoue, Tetsutaro Hayashi, Jun Teishima, Masaki Shiota, Wataru Yasui,
and et al. 2019. "TUBB3 Reverses Resistance to Docetaxel and Cabazitaxel in Prostate Cancer" International Journal of Molecular Sciences 20, no. 16: 3936.
https://doi.org/10.3390/ijms20163936
APA Style
Sekino, Y., Han, X., Kawaguchi, T., Babasaki, T., Goto, K., Inoue, S., Hayashi, T., Teishima, J., Shiota, M., Yasui, W., & Matsubara, A.
(2019). TUBB3 Reverses Resistance to Docetaxel and Cabazitaxel in Prostate Cancer. International Journal of Molecular Sciences, 20(16), 3936.
https://doi.org/10.3390/ijms20163936